Tony Muchamuel

VP, Pharmacology & Toxicology at Kezar Life Sciences

Tony Muchamuel serves as Vice President, Toxicology and Pharmacology at Kezar Life Sciences, and has led nonclinical drug development efforts in immunology and oncology since 2016. Tony has performed research in the biopharmaceutical industry for more than 20 years including at Amgen, Onyx Pharmaceuticals, Proteolix, Corgentech Inc., and DNAX Research Institute. He has authored/coauthored 22 scientific publications and 8 US patent applications.

Tony attended San Francisco State University where he received his Bachelor of Science degree in Physiology and Master of Science degree in Clinical Science.

Location

San Francisco, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Kezar Life Sciences

Based in South San Francisco, Kezar Life Sciences is combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders–with the hope of helping people overcome their disease and live a better life.


Industries

Employees

11-50

Links